Oral Nutrition Supplementation in Hospitalized Patients
NCT ID: NCT02624752
Last Updated: 2019-03-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
63 participants
INTERVENTIONAL
2016-10-05
2018-08-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Medical and Health Economic Benefit of Oral Nutritional Supplements (ONS) in Ambulant Patients
NCT02470013
Oral Nutritional Supplementation in Hospital Patients
NCT01641770
Nutrition Supplementation in Cardiovascular Surgery Patients
NCT02961205
Health Economic Research on Oral Nutritional Supplements for Hospitalized Patients With Nutritional Risk
NCT06062914
Impact of the Time of Oral Nutritional Supplements (ONS) Consumption on Daily Alimentary Intakes of Malnourished Elderly
NCT01261663
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
1. Ensure Enlive (enhanced ONS) + standard menu; or
2. Standard of care (including standard menu and possibly ONS) Patients randomized will receive standard menu or standard menu plus enhanced oral nutritional supplements (ONS). Patients randomized to enhanced ONS, will receive one bottle of ONS Abbott Ensure Enlive (235 mL, 350 calories), or similar product, two times daily for 90 days.
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard of Care
Standard of care could include liberalized diet consisting of 3 meals and snacks served daily or the standard oral nutrition supplementation (ONS) routinely used in the hospital, as prescribed by the medical team.These routine meals and snacks are the "standard of care."
No interventions assigned to this group
Ensure
Patients randomized to Enhanced Oral Nutritional Supplementation (ONS) will receive the standard of care hospital menu (3 meals and snacks per day) plus 2 cans of Ensure (or similar product) per day while in hospital and will continue 2 cans per day of Ensure when discharged home until they have been receiving the enhanced ONS for a total of 90 days.
Ensure
Comparison of enhanced oral nutrition supplementation versus standard of care
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ensure
Comparison of enhanced oral nutrition supplementation versus standard of care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* over the age of 65 years
* malnourished (subjective global assessment categories B or C patients)
Exclusion Criteria
* are designated palliative care
* are currently suffering from refeeding syndrome
* have a pre-existing medical condition that prevents oral intake of full fluids,
* have an expected length of stay of less than 48 hours from the time of assessment
* have suspected ischemic stroke as cause for admission
* reside in a residential care home
* are unable to walk prior to current illness.
* are pregnant/breastfeeding
* have a current diagnosis of diabetic ketoacidosis or hyperglycemic hyperosmolar syndrome
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Adam Rahman, MD, FRCPC
Role: PRINCIPAL_INVESTIGATOR
St.Joseph's Health Care, London ON
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
LHSC-University Hospital
London, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SIG2014F-08B
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.